OMNIlife science is an established medical technology company focused on engineering, manufacturing and distributing hip and knee replacement implants. The company is based in East Taunton, MA and is led by President and CEO George Cipolletti. OMNIlife has developed a robotics and navigation platform called OMNInav™, which uses a proprietary computer-assisted robotic cutting guide technology named OMNIplasty™. OMNInav is FDA cleared for hip replacement. The company plans to use recent financing proceeds to expand its hip and knee implant product lines and to complete commercial development of its OMNInav hip replacement solution. OMNIlife closed a $27.5M debt financing to support these efforts.

Total raised

$28M

Funding rounds

1

Latest round

Equity

Latest activity

Apr 2014